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ABSTRACT Each aminoacyl-tRNA synthetase must func-
tionallydtgh its cognate tRNAs from all others. We have
determined the minimum number of changes required to
transform a leucine amber suppressor tRNA to serine identity.
Eight changes are required. These are located in the acceptor
stem and in the D stem.
Correct recognition of tRNAs by aminoacyl-tRNA syn-
thetases (AASs) is a prerequisite for accurate protein synthesis
in the cell. Each of the 20 AASs must recognize and ami-
noacylate its own set of isoaccepting tRNAs and reject all
others. Elements that facilitate the aminoacylation of a tRNA
by its cognate AAS are termed recognition elements and must
play a major role in maintaining the amino acid specificity
(identity) of all tRNAs in vivo (1, 2). Recognition elements
include nucleotides that are specifically contacted by an AAS
(2, 3). They can also be nucleotides with indirect effects. For
example, some nucleotides dictate a particular tRNA confor-
mation that is required for proper orientation of nucleotides
with which the AAS specifically interacts (3-5). Finally,
recognition elements can be distinctive structural features that
are directly recognized by an AAS (6, 7). Most nonmitochon-
drial tRNAs 'have similar structural features, including an
extra loop that contains 4 or 5 nucleotides (type I). In Esch-
erichia coli, however, serine, tyrosine, and leucine tRNAs are
distinguished from all other isoaccepting groups by the pres-
ence of a large extra stem-loop (type II). This structural
feature could be an important determinant of their recognition
with respect to both cognate and noncognate AASs.
One way to determine the requirements for tRNA identity
is to change the tRNA so that it is aminoacylated with a
different amino acid. This approach was taken 20 years ago
when attempts were made to genetically select variants of the
E. coli tyrosine amber suppressor gene, which would insert a
different amino acid in response to the amber anticodon
(8-10). Several such mutants were isolated. They occurred in
the first and second base pairs of the acceptor stem and in the
fourth nucleotide from the 3' end of the tRNA. In every case,
the amino acid inserted was glutamine (8, 9, 11-14). Attempts
to find other changes in identity failed, probably because ofthe
requirement for multiple changes in order to effect other
identity changes. When it became possible to synthesize tRNA
genes, we returned to this approach and showed that we could
change the identity ofa tRNALeU amber suppressor to tRNAser
by making 12 nucleotide changes (15). Subsequently, this
approach was taken to show that the G3-U70 base pair in the
acceptor stem oftRNAAIa is required for its in vivo identity (16,
17). Similar studies have provided important information
about the requirements for the in vivo identity oftRNAPhe (18),
tRNAAm (19), tRNALYS (20), and tRNAGhl (21).
An intrinsic limitation ofthe in vivo approach is the require-
ment for the CUA anticodon. Introduction of this anticodon
into a tRNA can itself lead to a change in identity. In
retrospect, this should have been clear early on when it was
discovered that the amber suppressor allele ofa tRNATrP gene
inserts glutamine (22). Recently, we have synthesized amber
suppressor tRNA genes for all 20 isoaccepting groups in E. coli
(23, 24). Five ofthese tRNAs (Ile-1, Gly-2, Metf, Glu, and Trp)
insert glutamine and six others (Ile-2, Arg, Metm, Asp, Thr,
and Val) insert lysine (25). This result confirms Kisselev and
Frolova's (26) and Schulman and Goddard's (27) long-held
conviction that AASs recognize anticodon nucleotides, and
there is now much additional evidence to support that notion
(2). Recently, Schulman and coworkers (28, 29) have inserted
different anticodons into the E. coli tRNAMet initiator and have
shown that it will initiate polypeptide chains with the amino
acid corresponding to the identity ofthe new anticodon. Thus,
the in vivo approach has been a powerful tool for detecting
recognition of elements in the anticodon.
A successful identity swap necessitates supplying correct
positive elements for the desired AAS. In addition, it is
necessary to discourage aminoacylation by the original AAS
by removing its positive recognition elements from the
tRNA. We found that 12 nucleotide changes were required to
change the tRNALeu amber suppressor to tRNAser identity
(15). However, it was not established that this was the
minimum set of changes required to change the tRNAI-eU
amber suppressor to tRNASer identity. Moreover, because
tRNALeu contains a long extra stem-loop, as does tRNASer,
it was not possible to directly test the effect of this structural
feature on recognition.
In this paper, we describe our efforts to determine the
minimum number of base changes required to effect the
complete change of identity of tRNAIeu to tRNASer and to
determine the effect of structural features on the identity of
tRNAser, tRNALeU, and tRNATYr. As in our original work,
synthetic tRNA amber suppressor genes, expressed in E.
coli, were assayed for their in vivo specificity by determining
the amino acid sequence of dihydrofolate reductase (DHFR)
synthesized from an engineered gene containing an amber
mutation at codon 10. A second, more diagnostic assay for
serine insertion utilized an amber mutation at the active site
serine in the /3-lactamase gene. Since this serine is essential
for /3-lactamase activity, growth of E. coli containing this
gene on ampicillin indicates the presence of an active serine
amber suppressor.
MATERIALS AND METHODS
Strains and Plasmids. E. coli XAC-1 is F'lacI373lacZuli8am-
proB+/A(lacproB).,11, nalA, rif, ara, argEam. Plasmid pJN10
is derived from plasmids pBR322 and a derivative of
pEMBL8+ (30), pEMBL8+,-T. pEMBL8+.-T has an am-
ber mutation at the active-site serine (residue 68) of the amp
Abbreviations: AAS, aminoacyl-tRNA synthetase; DHFR, dihydro-
folate reductase; LSM6, leucine to serine mutant 6.
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gene and a transcription termination sequence (15) inserted
into the Pst I/HindIII sites of the polylinker. The 1769-base-
pair (bp) Pvu I/Pvu II fragment from pEMBL8+.-T con-
taining a portion of the amp gene, the replication origin, and
the polylinker was ligated to the 2820-bp Pvu I/Pvu II
fragment of pBR322 that carries the tet gene. Before pJN10
was constructed, the EcoRI site in pBR322 was removed by
digesting the plasmid with EcoRI, filling in the 5' termini with
Klenow, and ligating. Plasmid pDAYQ encodes the gene
conferring resistance to chloramphenicol, the gene for the lac
repressor, lacIQ, as well as the fol gene encoding DHFR,
with an amber mutation at residue 10 (25). The fol gene is
under control of the tac promoter (31).
Gene Synthesis. The tRNA genes were constructed from
synthetic oligonucleotides (made by the California Institute
of Technology Microchemical Facility) and were assembled
as described (15) and ligated into the unique EcoPJ/Pst I sites
located in the polylinker region of pJN10, which are flanked
by the lac promoter and rrnC terminator, 5' and 3', respec-
tively.
Determination of Suppressor Efficiency. Suppression effi-
ciencies of the mutant tRNAs were determined by assaying
,3-galactosidase activity (32) in strain XAC-1, which had been
transformed with pJN10 carrying a suppressor tRNA gene.
Purification of DHFR. DHFR was isolated from E. coli
strain XAC-1 carrying both the mutant tRNA gene borne on
plasmid pJN10 and plasmid pDAYQ. Cells were cultured in
L broth (10 g of Bactotryptone per liter, 10 g ofNaCl per liter,
5 g of yeast extract per liter) supplemented with 5 gg of
tetracycline and 30 gg of chloramphenicol per ml to an A600
of 0.4-0.8, at which time they were diluted 1:50 into minimal
M9 glycerol medium (32), which had been supplemented with
5 ,ug of tetracycline per ml, 30 tug of chloramphenicol per ml,
and 1 mM isopropyl ,-D-thiogalactopyranoside. The culture
was incubated, shaking at 370C for 12-18 hr, and the cells
were harvested. DHFR was purified from the cells as de-
scribed (15). N-terminal sequence analysis of DHFR was
carried out at either the University of Southern California
Microchemical Core Laboratory or the California Institute of
Technology Microchemical Facility.
RESULTS
Fig. 1A shows the nucleotides that are highly conserved in
tRNASer (or, as in the case ofbase pair 3 70, highly correlated
with tRNASer) and that are not found in tRNALeu5-our
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original starting tRNA. Fig. 1B shows the original leucine to
serine identity conversion, tRNA&UUAscr, with the 12 changes
indicated. In tRNA8uVASer, we had shifted the position of the
conserved nucleotides G18 and G19. The position of these
nucleotides relative to the D stem is conserved in serine
tRNAs. In tRNALCU, the position ofG18 and G19 is different.
We speculated that this structural feature could play a role in
recognition by serine AAS and, therefore, altered the leucine
D loop to introduce a serine-like configuration (Fig. 1B). We
examined the contribution of these mutations to serine iden-
tity in LSM6 (leucine to serine mutant 6; Fig. 2). The D loop
has the original wild-type tRNAI-U sequence configuration,
while the mutations in the D stem and acceptor stem are
retained. This suppressor (LSM6) inserted serine exclusively
at 40%6 efficiency (Table 1). Therefore, the changes originally
made to the D loop of tRNAjuuAs were not only unnecessary
for serine identity but were also likely responsible for its poor
suppression efficiency. The eight changes in LSM6 success-
fully converted the identity of tRNAI-U to tRNAser. The task
then was to determine which of these changes were neces-
sary.
In all tRNASer, base pair 11-24 is a C-G and in tRNALeu5 it
is a USA. We examined the contribution of this D-stem base
pair to serine identity by altering LSM6 to create a new
mutant, LSM4 (Fig. 2) with a U11A24 base pair. This
variant, while an efficient suppressor (Table 1), inserted a
mixture of amino acids: serine (16%), glutamine (39%), and
leucine (38%). Clearly, base pair C11G24 plays a role in
serine identity. We wondered whether a U-G base pair would
be acceptable at this position. This variant (LSM11; Fig. 2)
suppressed the A-lactamase amber sufficiently to enable
growth in the presence of ampicillin; however, the specificity
assay revealed that LSM11 inserts leucine (62%), glutamine
(33%), and <1% serine (Table 1). This result suggests that
ClH plays an important structural or chemical role in serine
identity.
We then set out to determine which of the original changes
in the acceptor stem were actually necessary, by changing
LSM6 one base pair or nucleotide at a time. In LSM10 (Fig.
2), position 73 has been changed back to an A. This tRNA
variant inserts exclusively leucine (Table 1). In LSM12, base
pair 2-71 was changed to the original leucine base pair (COG)
and in LSM13, position 72 was changed to the original U.
Both of these mutants insert little or no serine and predom-
inantly leucine and glutamine, indicating that these positions
are important for serine identity. In LSM9, the base pair at
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FIG. 1. (A) Composite of E. coli tRNAser. Nucleotides highly conserved in or correlated with tRNASer and not found in tRNAUe5 are
indicated. Adapted from ref. 15. (B) tRNAL~ej with 12 base changes predicted to convert the tRNA to serine identity. Adapted from ref. 15.
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3 70 has been changed to the CG found in tRNA Juu5. This
tRNA inserts predominantly leucine (72%o) and some serine
(20%6) and glutamine (6%), suggesting that this position is also
important for serine identity. Because seine isoacceptors
have not only A*U at position 3*70 (LSM6) but also UA, we
created LSM14 (Fig. 2). Surprisingly, this tRNA inserts
predominantly leucine (65%) along with glutamine (19%o) and
serine (11%) (Table 1). This unexpected result will be ad-
dressed in the Discussion. From these reversion studies, it is
apparent that all of the original changes made in the acceptor
stem of tRNA&5UuA were necessary to effect its conversion
from leucine to serine identity. The eight changes in LSM6
are therefore sufficient and necessary to alter tRNA'-eu' to
serine identity in vivo.
The eight changes in LSM6 do not necessarily constitute all
ofthe elements recognized by serine AAS. Some recognition
elements could already have been present in tRNA'eu5. One
obvious feature is the large type II extra stemloop common
to both isoaccepting groups. To investigate the role of this
structural feature in tRNA identity, we have constructed
tRNAser, tRNALeU, and tRNATYr amber suppressor genes in
which the large type II extra stem-loop is replaced by a
consensus type I extra loop.
A survey of the E. coli type I extra loop sequences (33)
revealed a consensus sequence of RRGUC (where R is
purine). Using methods previously described (15), we syn-
thesized altered amber suppressor genes in which the extra
loop sequences of tRNAWYA, tRNA&GA, and tRNAIA were
Table 1. Suppression efficiency of various LSM constructs
Suppression efficiency,
% wild-type Growth on Specificity (% amino acid
tRNAcUA 8-galactosidase ampicillin inserted at DHFR.1o)
Leu 52-59 Leu (99)
Ser 34-52 + Ser (92)
Leu--Ser 0.5-1 + Ser (90), Leu (10)
LSM6 33-49 + Ser (92)
LSM4 35-48 + Leu (38), Gin (39), Ser (16)
LSM11 11-19 + Leu (62), Gin (33), Ser (<1)
LSM10 20-35 Leu (99)
LSM12 5-9 Leu (91), GIn (9)
LSM13 12 + Leu (15), Gin (78), Ser (<1)
LSM9 11-12 + Leu (72), Gin (6), Ser (20)
LSM14 14-16 + Leu (65), Gin (19), Ser (11)
Values for percentage amino acid inserted may not total 100%, because background levels of <5%
for any amino acids are not included, with the exception of serine. While the values given for serine
inserted are <5% in some cases, the ability to confer ampicillin resistance indicates that the mutant must
be inserting some low level of serine. Estimates for percentage glutamine inserted include glutamic acid.
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Table 2. Suppression efficiency of extra loop deletion mutants
Suppressor Efficiency,* % Specificity
Tyr
TyrA
Ser
SerA
Leu
LeuA
64-73
4
75
28-34
64-78
26-35
Tyr
80%o Gln, 20%o Tyr
Ser
95% Gln, 5% Ser
Leu
Leu
*This experiment was performed independently of the one described
in Table 1 and gave somewhat higher efficiencies for the serine and
leucine suppressors.
altered to have the 5-base consensus sequence: A44-G45-G46-
U47-C4. These tRNAs were designated tRNAserA, tRNATYrA,
and tRNALeUA. Each tRNA suppressor was assayed for
suppression efficiency and for specificity (Table 2). Both
tRNASerA and tRNALeUA are reasonably efficient suppres-
sors, although somewhat less efficient than their wild-type
controls. tRNATYrA is only 4% efficient. Both tRNATYrA
and tRNASerA insert predominantly glutamine, whereas
tRNALeUA inserts exclusively leucine. This suggests that the
extra stem-loop may be a more important recognition ele-
ment for serine and tyrosine AAS than for leucine AAS.
DISCUSSION
The results of this study confirm and extend our earlier
conclusion that elements necessary for serine identity in vivo
reside in the acceptor stem and D stem of the tRNA. It is
shown here that the extra stem-loop is an additional element
that contributes to serine identity. A wide distribution of
recognition elements is known for yeast tRNAPhe (34) and E.
coli tRNAG0n (3). This situation stands in contrast to the
distribution of recognition elements in other tRNAs such as
E. coli alanine (16, 17), methionine, and valine (35), for which
recognition elements seem to be primarily restricted to a
single region. Because the in vivo identity of tRNAPer de-
pends on elements in three distinct regions, and within the
acceptor stem involves at least six nucleotides, changing the
identity of any tRNA to that of serine presents a particularly
challenging task. On the other hand, a swap to serine identity
does not encounter a difficulty seen in other tRNAs. The
anticodon is not expected to be a recognition element in
tRNA13r so that the necessity to have the amber anticodon is
not a problem.
The relationship between the in vivo identity ofa tRNA and
its suppression efficiency is not necessarily straightforward.
The four changes that were originally made in the D loop of
tRNALeu5 were shown here to have no measurable effect on
serine identity when they were eliminated in LSM6. Thus,
the special context ofthe conserved nucleotides in the D loop
of serine tRNAs is not a feature of tRNAser identity per se.
However, the configuration of these D-loop nucleotides in
LSM6 did have a large positive effect on suppression effi-
ciency. Because the original tRNAI-ser and LSM6 differed
in suppression efficiency but not in identity, it seems that
poor suppression efficiency did not reflect a deficiency in the
requisite recognition elements. Rather, the low suppression
efficiency of the original mutant may reflect problems asso-
ciated with processing (19), stability, translation efficiency
(24, 36), or presentation of recognition elements. Under some
circumstances, however, poor suppression efficiency could
directly reflect a deficiency in the recognition elements of a
variant. A variant containing only a subset of positive ele-
ments for any one of the 20 AASs could have a low suppres-
sion efficiency simply because of a low efficiency of ami-
noacylation. LSM12, a low efficiency leucine suppressor,
may be an example of such a tRNA.
Of the original 12 changes made to convert tRNALeu to
tRNASer, only those at base pairs 11-24, 2-71, and 3 70, and at
positions 72 and 73 were absolutely required. The majority of
these changes involved nucleotides within the acceptor stem.
*With the exception of base pair 3 70, all nucleotide changes
necessary to change tRNALeU to tRNAser were to bases that
are absolutely conserved in E. coli serine tRNAs. In two
variants, changing a nucleotide that conferred seine identity
in LSM6 to the wild-type nucleotide for tRNAL-eu reduced
serine identity and increased leucine identity. Changing G73
to A (LSM10) gave a tRNA with complete leucine identity.
Similarly, changing G2-C71 to C2*G71 (LSM12) gave a tRNA
with an identity that was 91% leucine and 9%o glutamine.
There are two possible, but not mutually exclusive explana-
tions for these types of results. G73 and G2-C71 may be
positive elements for serine AAS and the alternatives A73
and C2-G71 may be positive elements for leucine AAS. Thus,
the presence ofA73 and C2-G71 in LSM10and LSM12 would
effectively discourage aminoacylation by serine AAS and
would facilitate aminoacylation by leucine AAS. Although
G73 and G2 C71 are clearly required for serine identity in
vivo, it is difficult from these experiments alone to assign
their effects on identity to recognition by leucine and serine
AAS. Changing the identity of a tRNAser amber suppressor
to that of leucine (the reverse identity swap) and measuring
the aminoacylation kinetics of various mutants may help
define the leucine and serine recognition elements.
We were surprised that two variants, LSM6 (A3-U70) and
LSM14 (U3A70), differed in serine identity. These mutants
differed only at base pair 3 70 and each contained a base pair
at this position that is found in E. coli tRNAer. It is believed
that proteins recognize the minor but not the major groove of
internal stretches of helical RNA (37). In the minor groove,
the constellation of hydrogen bond acceptors and donors
does not differ between A-U and U-A base pairs (38). Con-
sequently, based on current ideas about RNA-protein inter-
actions, it does not seem that the observed in vivo identity of
LSM6 and LSM14 can be strictly explained based on differ-
ential recognition of A-U and UA at position 3-70. It is
possible, however, that both LSM6 and LSM14 lack some
element that has not yet been defined and, therefore, are not
optimal substrates for serine AAS. In this case, the large
difference in their in vivo identity could be due to subtle
differences in their interaction not only with serine AAS but
also with the competing leucine and glutamine AASs.
Clearly, in vitro kinetic analyses of these mutants will help to
resolve this problem.
Several amber suppressor tRNAs are misacylated by glu-
tamine AAS (8, 9, 11-14, 25) as are several of the LSMs. The
structure of the tRNAG'n glutamine AAS complex now pro-
vides some explanation for that fact (3). The crystal structure
reveals specific contacts between glutamine AAS and all 3
bases of the anticodon (39). The amber anticodon CUA has
2 bases in common with the CUG glutamine anticodon.
Therefore, for an amber suppressor to retain its original
identity, it must be a better substrate for its cognate AAS than
it is for glutamine AAS. The tRNAGln glutamine AAS com-
plex also reveals that fraying of the first base pair in the
acceptor stem is an important element for recognition by
glutamine AAS. This could explain, in part, the high level of
glutamine inserted (78%) by LSM13, which has a Gl U72
pair.
tRNASerA and tRNATYrA amber suppressors were both
misacylated by glutamine AAS, whereas tRNAVLeJ retained
its identity. This suggests that the extra stem-loop is a more
important recognition element for serine and tyrosine AAS
than it is for leucine AAS. Because the structure of the
tRNAGIn-glutamine AAS complex shows that glutamine
AAS binds along the inside ofthe L structure ofthe tRNA and
makes no obvious contacts with the extra loop, it is not likely
Biochemistry: Normanly et al.
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that glutamine AAS recognizes either the size or configura-
tion of this structure. Thus, the misacylation of tRNATYrA
and tRNASerA by glutamine AAS is best explained as the
consequence of a loss of a positive element for serine and
tyrosine AAS.
The extra stem-loop is clearly indicated as a serine rec-
ognition element by footprinting studies ofthe E. coli (40) and
yeast (41) tRNASer-serine AAS complex. Moreover, our
observed in vivo effect of the extra stem-loop on serine
identity is consistent with recent in vitro studies of tRNATYr
and tRNAser, which show that certain alterations ofthe extra
stem-loop can affect the kcat/Km for aminoacylation by serine
AAS (7, 42). It is likely that the positive effect of the extra
stem-loop on serine identity is due to its structure rather than
its sequence since the extra stem-loop nucleotides are not
strictly conserved in E. coli serine isoacceptors.
The in vivo approach that we have used in this work
measures the outcome of competition between all AASs for
a particular tRNA. Thus, tRNAs with single identities as well
as those with multiple identities are revealed by this method.
By examining the amino acid identity of a bank of mutants,
it is possible to delineate the sites in a tRNA that determine
its identity. Moreover, because the results of these types of
experiments reveal which AASs are competing for a given
substrate, they provide information about the elements that
are recognized by competing AASs. With a detailed knowl-
edge of the suppression efficiency, identity, and, addition-
ally, the aminoacylation kinetics of a series of systematically
related mutants, it should be possible to delimit the elements
necessary for maintaining specificity. Measurement of the in
vitro aminoacylation kinetics ofT7 transcripts corresponding
to the LSM series remains to be done. Such studies, along
with the three-dimensional structure of serine AAS (43),
should further our understanding of tRNASer recognition.
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